VSAL_I2938 is produced via heterologous expression in E. coli, followed by affinity chromatography using its His tag . Key steps include:
Cloning: The VSAL_I2938 gene (locus tag in strain LFI1238) is inserted into an E. coli expression vector .
Expression: Induced under optimized conditions to maximize soluble protein yield .
Purification: Nickel-based affinity chromatography, with final buffer exchange into Tris/PBS containing trehalose for stability .
Challenges during production include avoiding protein aggregation and minimizing endotoxin contamination, common issues with membrane proteins .
VSAL_I2938 belongs to the UPF0761 family, which includes uncharacterized membrane proteins. Its exposure on the bacterial surface suggests potential antigenic properties, though direct evidence is limited .
Comparative studies show that other A. salmonicida membrane proteins (e.g., VapA) elicit strong antibody responses in fish, hinting at VSAL_I2938’s possible utility in vaccine development .
The VSAL_I2938 gene is located on the chromosome of A. salmonicida strain LFI1238, distinct from plasmid-encoded virulence factors like iron transporters or acyltransferases .
Plasmid pVSAL320, which contributes to iron uptake in A. salmonicida, does not interact directly with VSAL_I2938 .
Functional Role: The biological function of VSAL_I2938 remains uncharacterized. Homology searches yield no significant matches to proteins with known enzymatic or receptor activities .
Pathogenicity Link: While A. salmonicida vaccines effectively control vibriosis, whether VSAL_I2938 contributes to protective immunity is untested .
Structural Studies: Cryo-EM or crystallography could clarify its membrane topology .
Knockout Models: Assessing virulence in VSAL_I2938-deficient strains may reveal its role in infection .
Vaccine Trials: Decorating virus-like particles (VLPs) with VSAL_I2938 could mimic successful VapA-based strategies .
KEGG: vsa:VSAL_I2938
STRING: 316275.VSAL_I2938
VSAL_I2938 is a UPF0761 family membrane protein found in Aliivibrio salmonicida (strain LFI1238), previously classified as Vibrio salmonicida. The protein consists of 310 amino acids and has a UniProt accession number of B6EGQ7 . The significance of this protein lies in its potential role in bacterial membrane function and possible involvement in pathogenicity mechanisms of A. salmonicida, a known fish pathogen.
The amino acid sequence reveals characteristic features of integral membrane proteins, including multiple hydrophobic regions that likely form transmembrane domains. The sequence (MEEKFKYSLRISWSYFLFLKQRIIHDRLTVSAGYMAYITLLSLVPLVTVLLSVLSQFPIFSGAGETVQEFVIQNFVPAAS DAVEGSLFISNTGKMTAVGSGFLFVASVMLISAIDRS...) suggests a complex tertiary structure with potential functional domains . Studying VSAL_I2938 provides insights into membrane protein evolution, bacterial adaptation mechanisms, and potential targets for antibacterial interventions in aquaculture settings.
When comparing VSAL_I2938 to other UPF0761 family proteins such as E. coli's YihY protein, researchers can observe both structural similarities and species-specific adaptations. The E. coli UPF0761 membrane protein YihY (UniProt ID: B7L9D9) consists of 290 amino acids compared to VSAL_I2938's 310 amino acids . Both proteins share characteristic hydrophobic regions and predicted transmembrane domains typical of the UPF0761 family.
| Feature | VSAL_I2938 (A. salmonicida) | YihY (E. coli) |
|---|---|---|
| Length | 310 amino acids | 290 amino acids |
| UniProt ID | B6EGQ7 | B7L9D9 |
| Key conserved motifs | MTAVGSG, VSAL_I | MTAVGAC, YihY |
| Predicted transmembrane domains | 8-9 domains | 7-8 domains |
| Expression system challenges | Hydrophobicity, potential toxicity | Similar hydrophobicity issues |
These comparative analyses provide valuable insights into the evolutionary conservation of UPF0761 family proteins across different bacterial species and their potential functional significance .
For prokaryotic expression systems (such as E. coli):
Codon optimization is essential due to potential codon bias between A. salmonicida and the expression host
Fusion tags (particularly His-tags) facilitate purification and can enhance solubility
Selection of appropriate promoters (such as T7) and host strains (such as BL21(DE3)) optimized for membrane protein expression
Growth at lower temperatures (16-20°C) after induction to reduce inclusion body formation
Addition of specific membrane-mimicking environments or detergents during expression
For eukaryotic expression systems (when prokaryotic systems prove challenging):
Yeast (Pichia pastoris) systems can provide a more native-like membrane environment
Insect cell systems may be advantageous for larger membrane protein complexes
Mammalian cell systems might be necessary if post-translational modifications are critical
The storage and handling of the expressed protein should follow established protocols, including storage at -20°C or -80°C with 50% glycerol to maintain stability, and avoidance of repeated freeze-thaw cycles that can damage the protein structure .
Expression of membrane proteins like VSAL_I2938 presents significant challenges due to their hydrophobic nature, potential toxicity to host cells, and complex folding requirements. Implementing specialized strategies is essential for successful production:
Addressing translation initiation problems:
Design constructs with fusion tags on both N and C termini to identify full-length proteins and distinguish them from truncated products
Implement a stepwise imidazole gradient during purification to separate truncated products from full-length proteins
Optimize the ribosome binding site and distance from the start codon to enhance translation initiation efficiency
Overcoming protein toxicity:
Utilize tightly controlled inducible promoter systems (such as the lac or tet promoters)
Employ expression hosts specifically engineered for toxic protein expression (C41/C43 strains)
Consider cell-free protein synthesis systems for highly toxic membrane proteins
Implement a leaky expression system with lower induction levels over longer periods
Enhancing membrane protein folding:
Co-express molecular chaperones (GroEL/GroES, DnaK/DnaJ) to assist with protein folding
Include specific lipids or detergents in the growth medium
Express the protein as a fusion with highly soluble partners (MBP, SUMO, or TrxA)
Select an expression temperature that balances protein production rate with proper folding (typically 16-20°C)
Researchers should systematically optimize these parameters through small-scale expression trials before proceeding to larger-scale production, monitoring protein expression using techniques such as Western blotting with antibodies against the fusion tags .
Purifying membrane proteins like VSAL_I2938 requires specialized approaches to maintain structural integrity and functional activity. A systematic purification strategy should include:
Membrane extraction and solubilization:
Harvest cells and disrupt by sonication or homogenization in appropriate buffer systems
Isolate membrane fractions through differential centrifugation
Solubilize membrane proteins using detergents appropriate for downstream applications
Mild detergents (DDM, LMNG) for functional studies
Stronger detergents (SDS, Triton X-100) for maximum extraction but potential denaturation
Optimize detergent:protein ratios through small-scale trials
Affinity chromatography and further purification:
Utilize His-tag affinity chromatography as the initial capture step
Implement stepwise imidazole gradient (20-300mM) to minimize non-specific binding
Include appropriate detergents in all buffers to maintain protein solubility
Consider secondary purification steps:
Size exclusion chromatography to remove aggregates and ensure homogeneity
Ion exchange chromatography for further purification if isoelectric point allows
Maintaining protein stability post-purification:
Store in buffer containing Tris/PBS, 50% glycerol at pH 8.0
Add stabilizing agents such as specific lipids or mild detergents
Aliquot to avoid freeze-thaw cycles and store at -20°C or -80°C
For functional studies, reconstitute in lipid bilayers or nanodiscs to maintain native-like environment
Validation of protein activity should be performed using functional assays specific to predicted activities of UPF0761 family proteins, potentially including transport assays or binding studies with predicted interaction partners .
Comprehensive characterization of VSAL_I2938 requires multiple complementary techniques addressing different aspects of protein structure and function:
Structural characterization:
Circular Dichroism (CD) spectroscopy:
Provides information on secondary structure content (α-helices, β-sheets)
Useful for monitoring structural changes under different conditions
Cryo-Electron Microscopy (Cryo-EM):
Increasingly powerful for membrane protein structure determination
Can visualize protein in a near-native lipid environment
X-ray crystallography (challenging but valuable):
Requires successful crystallization, often using lipidic cubic phase methods
Provides atomic-level resolution if successful
Nuclear Magnetic Resonance (NMR) spectroscopy:
Functional characterization:
Liposome reconstitution assays:
Incorporate purified protein into liposomes to assess transport function
Can use fluorescent probes to monitor substrate movement
Microscale Thermophoresis (MST) or Surface Plasmon Resonance (SPR):
Determine binding affinities for potential substrates or interaction partners
Allow quantitative assessment of protein-protein interactions
Electrophysiology techniques:
For potential channel or transporter functions
Can be combined with site-directed mutagenesis to identify functional residues
Computational approaches:
Molecular dynamics simulations to predict protein behavior in membranes
Homology modeling based on related UPF0761 family proteins
Protein-protein interaction prediction tools to identify potential binding partners
Through strategic combination of these techniques, researchers can develop a comprehensive understanding of VSAL_I2938's structural features and functional mechanisms in bacterial membranes.
VSAL_I2938 from Aliivibrio salmonicida presents valuable opportunities for studying fish pathogens, particularly in the context of cold-water vibriosis in salmonid aquaculture. Researchers can leverage this protein through multiple experimental approaches:
Virulence and pathogenicity studies:
Generate VSAL_I2938 knockout or knockdown strains of A. salmonicida
Assess changes in bacterial growth, survival, and pathogenicity
Compare wild-type and mutant strains in infection models
Overexpress VSAL_I2938 to evaluate potential changes in virulence factors
Investigate its role in biofilm formation using crystal violet assays and microscopy
Assess temperature-dependent expression patterns correlating with disease outbreaks
Immunological applications:
Use purified recombinant VSAL_I2938 to:
Develop specific antibodies for diagnostic applications
Create ELISA-based detection systems for A. salmonicida
Study host immune responses to specific bacterial membrane components
Evaluate potential as a vaccine component:
Comparative analyses across fish pathogens:
Examine conservation of UPF0761 family proteins across various fish pathogens
Correlate structural variations with host specificity or virulence differences
Use as a molecular marker for evolutionary studies of fish pathogens
These approaches can yield valuable insights for aquaculture disease management and contribute to fundamental understanding of host-pathogen interactions in marine environments.
Investigating VSAL_I2938's interactions with host cells or other bacterial proteins requires specific methodological approaches that accommodate its membrane-bound nature:
For protein-protein interactions:
Proximity-based labeling methods:
BioID or APEX2 fusion proteins to identify proximal proteins in vivo
Can capture transient interactions in native membrane environments
Co-immunoprecipitation with membrane-specific modifications:
Yeast two-hybrid adaptations for membrane proteins:
Split-ubiquitin membrane yeast two-hybrid system
MYTH (membrane yeast two-hybrid) system
Fluorescence-based interaction assays:
FRET (Förster Resonance Energy Transfer) for direct interaction detection
BiFC (Bimolecular Fluorescence Complementation) for visualizing interactions in situ
For host-pathogen interaction studies:
Cell culture models using fish cell lines:
Assess binding to specific cell types
Evaluate cellular responses to purified VSAL_I2938
Fluorescently-labeled protein tracking:
Monitor localization during infection processes
Identify potential host cell receptors
Proteomics approaches:
Crosslink VSAL_I2938 to host cell proteins during infection
Mass spectrometry identification of interaction partners
Data analysis approaches:
Implement network analysis to map interaction landscapes
Utilize computational docking to predict binding interfaces
Develop quantitative binding assays to determine affinity constants
Perform coevolutionary analysis to identify potential interaction partners
When interpreting interaction data, researchers should consider the physiological relevance of detected interactions and validate key findings through multiple complementary approaches.
Comparative analysis of UPF0761 family proteins across bacterial species provides a powerful framework for understanding bacterial adaptation to diverse environments. For VSAL_I2938 research, this approach offers several valuable strategies:
Sequence-based comparative analyses:
Multiple sequence alignment of UPF0761 family proteins:
Identify conserved domains suggesting critical functional regions
Detect variable regions potentially associated with species-specific adaptations
Compare VSAL_I2938 (A. salmonicida) with YihY (E. coli) to identify marine-specific features
Phylogenetic analysis to trace evolutionary relationships:
Structure-function comparative studies:
Homology modeling based on available structures:
Generate structural models of VSAL_I2938 and related proteins
Compare predicted structural features across environmental isolates
Domain swapping experiments:
Create chimeric proteins combining domains from different UPF0761 family members
Assess functional changes to identify domain-specific activities
Site-directed mutagenesis of conserved residues:
Environmental adaptation analysis:
Compare UPF0761 proteins from bacteria adapted to different temperatures:
Cold-adapted (psychrophilic) species like A. salmonicida
Mesophilic species like E. coli
Thermophilic species if available
Examine responses to environmental stressors:
Expression patterns under osmotic stress
Regulation during temperature shifts
Role in biofilm formation across species
This comparative approach can reveal how membrane proteins evolve to support bacterial adaptation to specific niches, potentially identifying molecular mechanisms that enable pathogenicity in specific environments .
Contradictory results in VSAL_I2938 functional studies can stem from multiple factors. Researchers should implement a systematic troubleshooting approach:
Sources of experimental variation to consider:
Expression system differences:
Expression host (E. coli vs. other systems) may affect protein folding
Fusion tags can influence protein behavior and interaction profiles
Growth conditions (temperature, media composition) impact protein quality
Purification and handling variables:
Experimental assay considerations:
Sensitivity and specificity of detection methods
Physiological relevance of in vitro conditions
Potential interference from contaminants or buffer components
Systematic resolution strategies:
Standardize experimental protocols:
Create detailed standard operating procedures
Document all variables that might impact results
Implement internal controls for each experiment
Validate protein quality:
Employ orthogonal approaches:
Test function using multiple independent assays
Validate key findings in different experimental systems
Develop structure-function correlations to explain discrepancies
When publishing, researchers should transparently report all experimental conditions and acknowledge limitations, allowing the scientific community to properly contextualize and build upon findings .
Membrane proteins like VSAL_I2938 frequently present expression and purification challenges. Implementing a methodical troubleshooting workflow can overcome these obstacles:
Low expression yield troubleshooting:
Sequence optimization:
Check for rare codons and optimize if necessary
Verify correct reading frame and start/stop codons
Ensure appropriate ribosome binding site placement
Expression conditions optimization:
Expression strain selection:
Test specialized strains (C41/C43, Rosetta, Origami)
Consider strains with additional tRNAs for rare codons
Evaluate strains with reduced protease activity
Protein solubility and purification issues:
Detergent screening matrix:
Test mild detergents (DDM, LMNG) to harsh detergents (SDS)
Optimize detergent concentration for membrane solubilization
Consider detergent mixtures for enhanced extraction
Buffer optimization:
Chromatography troubleshooting:
For His-tag purification: optimize imidazole concentration in wash steps
For size exclusion: ensure appropriate column selection for membrane proteins
Consider on-column detergent exchange during purification
Protein degradation issues:
Add protease inhibitors throughout purification process
Reduce purification time and maintain cold temperatures
Test different storage conditions and cryoprotectants
Consider adding specific lipids to maintain protein stability
Systematic documentation of all troubleshooting steps creates valuable protocols for future work with VSAL_I2938 and related membrane proteins.
Developing and validating antibodies against membrane proteins like VSAL_I2938 requires rigorous characterization before application in experimental settings. The following systematic approach ensures antibody specificity and reliability:
Validation strategies for anti-VSAL_I2938 antibodies:
Specificity testing:
Epitope mapping:
Identify the specific epitope recognition using peptide arrays
Confirm accessibility of epitopes in the native protein context
Ensure epitopes are not in transmembrane regions unless antibodies are for denatured applications
Application-specific validation:
Quantitative validation parameters:
Sensitivity measurements:
Determine limit of detection using purified protein dilution series
Assess signal-to-noise ratio in relevant experimental contexts
Reproducibility assessment:
Test antibody performance across multiple protein preparations
Evaluate lot-to-lot consistency for polyclonal antibodies
Assess stability after multiple freeze-thaw cycles
Documentation requirements:
Comprehensive validation data should include:
Full blot images showing all bands and molecular weight markers
Controls demonstrating specificity
Quantitative measures of sensitivity and reproducibility
Catalog all validation conditions:
Proper antibody validation ensures reliable experimental outcomes and reproducibility in VSAL_I2938 research, particularly important given the challenges associated with membrane protein detection.
Emerging technologies offer new opportunities to overcome traditional challenges in membrane protein research, potentially revolutionizing studies of VSAL_I2938:
Advanced structural biology approaches:
Cryo-EM innovations:
Single-particle analysis with improved detectors and processing algorithms
Microcrystal electron diffraction for membrane proteins resistant to traditional crystallization
In situ structural determination within native membrane environments
Integrative structural biology:
Membrane mimetic systems:
Nanodiscs and lipid bilayer systems:
Improved membrane scaffold proteins for better stability
Customizable lipid composition to mimic A. salmonicida membranes
High-throughput reconstitution platforms for functional studies
Cell-free expression systems:
Computational and AI-driven approaches:
AlphaFold2 and similar AI platforms:
Improved prediction of membrane protein structures
Application to protein-protein interaction modeling
Integration with molecular dynamics simulations
Deep mutational scanning:
Gene editing and synthetic biology:
CRISPR-Cas9 applications in A. salmonicida:
Precise genome editing to study VSAL_I2938 in native context
Creation of reporter fusions for in vivo tracking
Development of conditional expression systems
Minimal synthetic membrane systems:
Bottom-up construction of functional membrane units
Testing isolated functions in defined environments
These emerging technologies promise to accelerate understanding of VSAL_I2938's structure, function, and role in bacterial pathogenicity .
Research on VSAL_I2938 extends beyond its specific role in A. salmonicida and can contribute to multiple scientific disciplines:
Comparative bacterial membrane biology:
Model system for cold-adapted membrane protein function:
Understanding how psychrophilic bacteria maintain membrane fluidity
Identifying structural adaptations for function at low temperatures
Comparing with mesophilic and thermophilic homologs for evolutionary insights
Membrane protein evolution across bacterial lineages:
Biotechnology applications:
Membrane protein engineering platforms:
Development of stable membrane protein scaffolds for biotechnology
Designer transport proteins for controlled molecular passage
Creation of membrane-based biosensors
Bioremediation and environmental monitoring:
Aquaculture disease management:
Novel therapeutic target development:
Identification of inhibitors specifically targeting VSAL_I2938
Development of antimicrobial strategies targeting membrane vulnerabilities
Combination approaches targeting multiple membrane components
Diagnostic improvements:
Fundamental membrane biophysics:
Model systems for membrane protein folding and stability:
Broad application of VSAL_I2938 research underscores the value of studying specialized membrane proteins from diverse bacterial species, with implications extending far beyond the initial research context.
The study of VSAL_I2938 and similar membrane proteins may offer novel approaches to combat antibiotic resistance, a growing concern in aquaculture:
Novel therapeutic target identification:
Membrane vulnerability exploitation:
Target membrane proteins essential for bacterial survival
Develop compounds that specifically disrupt VSAL_I2938 function
Create combination therapies targeting multiple membrane components
Structure-based drug design:
Alternative therapeutic strategies:
Anti-virulence approaches:
Target membrane proteins involved in virulence factor secretion
Develop compounds that inhibit biofilm formation
Create therapies that don't kill bacteria but reduce pathogenicity
Immune-based strategies:
Resistance mechanism understanding:
Membrane-based resistance mechanisms:
Study how membrane composition changes affect antibiotic penetration
Investigate the role of membrane proteins in efflux pump systems
Examine adaptations in membrane proteins following antibiotic exposure
Cross-resistance patterns:
Diagnostic and monitoring applications:
Early detection systems:
Develop rapid tests for antimicrobial resistance markers
Create biosensors detecting changes in membrane protein expression
Implement surveillance systems in aquaculture settings
Resistance prediction models:
These approaches represent promising alternatives to conventional antibiotics, potentially addressing the growing crisis of antimicrobial resistance in aquaculture and beyond.